On the day before the Nobel Prize for Chemistry is awarded to the developers of the novel CRISPR gene-splicing technology, Jan Miyasaki speaks to Stuart Newman, Professor of Cell Biology and Anatomy at the New York Medical College, about the technology, its applications, safety in human genetic engineering, and commercialized gene patenting.